Announcement of regulated information according to the L.3556 The company GR. SARANTIS S.A. announces, according to the article 21 of the L.3556/2007 and the article 11 of the Hellenic Capital Market Commission decision 1/434/3.
Announcement of regulated information according to the L.3556 The company GR. SARANTIS S.A. announces, according to the article 21 of the L.3556/2007 and the article 11 of the Hellenic Capital Market Commission decision 1/434/3.
On 09/07/2014, Wednesday and at 16:00 p.m., the A’ Repeated Ordinary General Shareholders’ Meeting of “GR. SARANTIS S.A.” took place at the company’s registered offices. During the General Meeting, shareholders representing 24,527,297 shares were present, corresponding to a 70.
Sarantis Group will release the H1 2014 consolidated financial results, according to the following schedule: Wednesday July 30th 2014 after ASE closing – Results Release, which will be available in the Athens Stock Exchange web page (www.
Following its announcement dated 15/10/2013 regarding the production transfer of face and body cream products ELMIPLANT, BIOTEN and KOLASTYNA from Romania to the Group’s production plant at Oinofoita, Greece, Sarantis Group announces that the production transfer was successfully completed within the first half of 2014.
Sarantis Group completed the acquisition of the Czech cosmetic trademarks company ASTRID T.M. More specifically, in the context of further strengthening its geographical footprint within the region of its operation and further enriching its own brand portfolio Sarantis Group signed an agreement for the acquisition of the 100% of the share capital of the company ASTRID T.
Announcement of a share buy back program The company GR. SARANTIS SA announces that the Ordinary General Shareholders Meeting that took place on 26/06/2014 approved a share buyback program through the Athens Exchange and according to article 16 of c.